Form 8-K - Current report:
SEC Accession No. 0001493152-26-028489
Filing Date
2026-06-12
Accepted
2026-06-12 16:50:36
Documents
13
Period of Report
2026-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 58716
2 EX-10.1 ex10-1.htm EX-10.1 199646
3 EX-10.2 ex10-2.htm EX-10.2 111384
  Complete submission text file 0001493152-26-028489.txt   588131

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nrxs-20260610.xsd EX-101.SCH 3014
5 XBRL LABEL FILE nrxs-20260610_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE nrxs-20260610_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3314
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 261087600
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)